BPA - AB QuantStudio 5 (ABI 7500 replace)

The Food and Drug Administration is forecasting a Blanket Purchase Agreement for the replacement of existing ABI 7500 PCR systems with AB QuantStudio 5 instruments across all seven microbiology laboratories. The ABI 7500 devices are being phased out due to the vendor's discontinuation of service and manufacturing, necessitating the acquisition of new units to maintain uninterrupted DNA and RNA screening operations. Each laboratory requires these instruments as they are critical for primary pathogen detection and molecular diagnostics. The procurement includes the base order plus four additional options years, ensuring sustained operational capacity over an extended period. The NAICS code 334516 indicates this is for medical and diagnostic laboratory equipment manufacturing, and the point of contact for inquiries is the Hfp Acquisition Liaison at hfpacquisitions@fda.hhs.gov, with the Contracting Officer position to be determined. The opportunity was posted on May 25, 2026, and no set-aside information has been specified.